• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

17026-42-5 ((+)-Dibenzoyl-D-tartaric acid)

1

Identification

(+)-Dibenzoyl-D-tartaric acid (+)-Dibenzoyl-D-tartaric acid
Name (+)-Dibenzoyl-D-tartaric acid
Formula C18H14O8
MW 358.3
CAS No. 17026-42-5
EINECS 241-097-1
Smiles O=C(O)[[email protected]@H](OC(C1=CC=CC=C1)=O)[[email protected]](OC(C2=CC=CC=C2)=O)C(O)=O
Synonyms 2,3-Dibenzoyl-D-tartaric acid; (2S,3S)-2,3-bis(benzoyloxy)succinic acid
InChI InChI=1S/C18H14O8/c19-15(20)13(25-17(23)11-7-3-1-4-8-11)14(16(21)22)26-18(24)12-9-5-2-6-10-12/h1-10,13-14H,(H,19,20)(H,21,22)/t13-,14-/m0/s1
2

Introduction

Background Information

3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance:White to off-white Solid EBNumber:EB000013561

Storage condition

Solubility

5

Mechanism and Indication

Signaling Pathways
Target
Research Area
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
(+)-Dibenzoyl-D-tartaric acid - No Development Reported
7

Safety Data of (+)-Dibenzoyl-D-tartaric acid

´╗┐Hazard Symbols : Xi
´╗┐Risk Statements : 36
Safety Statements : 26-36-37/39
WGKGermany : 3
8

Spectral Information

9

Suppliers List

10

Related Products

Other Forms of 17026-42-5

Name CAS No Formula MW

Recommended Compounds in

Name CAS No Formula MW

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

Protocol Reference

13

More Information

(+)-Dibenzoyl-D-tartaric acid

Tags: buy 17026-42-5 IC50 | 17026-42-5 price | 17026-42-5 cost | 17026-42-5 solubility | 17026-42-5 purchase | 17026-42-5 manufacturer | 17026-42-5 research buy | 17026-42-5 order | 17026-42-5 MSDS | 17026-42-5 chemical structure | 17026-42-5 Storage condition | 17026-42-5 molecular weight | 17026-42-5 mw | 17026-42-5 datasheet | 17026-42-5 supplier | 17026-42-5 cell line | 17026-42-5 NMR | 17026-42-5 MS | 17026-42-5 IR | 17026-42-5 solubility | 17026-42-5 Safe information | 17026-42-5 Qc and Spectral Information | 17026-42-5 Clinical Information | 17026-42-5 Clinical Trial | 17026-42-5 Route of Synthesis | 17026-42-5 storage condition | 17026-42-5 diseases and conditions | 17026-42-5 flash point | 17026-42-5 boiling point | 17026-42-5 melting point | 17026-42-5 storage condition | 17026-42-5 brand